NPRC/Institute
Intelligence & Technology Lab, Inc., Kaizu, Japan; Innovation Research Center, EPS Holdings, Inc., Tokyo, Japan.
Summary of Study
sublingual vaccine with RBD antigen and poly(I:C) adjuvant
Year Published
2023
References
DOI: 10.1093/biomethods/bpad017
Contact Info
Shin Nakamura: snakamura@itechlab.co.ip
Keywords
SARS-CoV-2, sublingual vaccine, receptor binding domain, immune response, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type